Table IVb.
SF | RE | VT | |||||
---|---|---|---|---|---|---|---|
Variable | Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | |
Intercept | 97.60 | (97.39, 97.82) | 95.69 | (95.28, 96.10) | 72.90 | (72.73, 73.08) | |
Major Depressive Disorder and Urinary Incontinence | |||||||
No MDD + UI | 93.92 | (93.64, 94.20) | 91.96 | (91.42, 92.49) | 68.04 | (67.81, 68.27) | |
MDD + No UI | 77.34* | (77.02, 77.67) | 62.16* | (61.55, 62.77) | 58.76* | (58.49, 59.02) | |
MDD + UI | 71.50* | (71.14, 71.87) | 55.33* | (54.65, 56.02) | 55.77* | (55.47, 56.07) | |
Cancer typec | |||||||
Bladder | 95.88 | (94.16, 97.60) | 95.20 | (92.19, 98.21) | 71.50 | (70.13, 72.86) | |
Breast | 96.82 | (95.93, 97.70) | 96.16 | (94.55, 97.77) | 71.26 | (70.54, 71.96) | |
Colorectal | 95.29 | (94.16, 96.41) | 93.71 | (91.65, 95.77) | 71.92 | (71.02, 72.83) | |
Endometrial/Uterine | 98.78 | (96.85, 100.70) | 99.11 | (95.56, 102.65) | 73.12 | (71.56, 74.68) | |
Lung | 88.06* | (86.14, 89.98) | 88.85 | (85.71, 91.98) | 65.33* | (63.85, 66.80) | |
Prostate | 96.85 | (96.01, 97.69) | 94.65 | (93.14, 96.17) | 73.14 | (72.47, 73.83) |
SF= social functioning; RE= role-emotional; VT=vitality.
Demographics and comorbidities adjustment set (index, referent): age at survey (65–74, 75–84, 85+), smoker (yes, no), race (other, white), gender (male, female), marital status (other, married), education (> high school, ≤ high school), high blood pressure, stroke, chronic lung disease (includes COPD, emphysema or asthma), gastrointestinal problems (including Crone’s, ulcerative colitis, or inflammatory bowel disease) diabetes, difficulty completing one or more activities (getting out of chair, use of toilet, walking, eating, dressing, bathing), joint pain, cardiovascular disease
Noncancer participants are referent for cancer type
Clinical significance for HRQOL scales defined using a minimally important difference (MID) equal to 1/3SD